These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 24193570
21. A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer. Fujita K, Yoshino E, Kawara K, Maeda K, Kusuhara H, Sugiyama Y, Yokoyama T, Kaneta T, Ishida H, Sasaki Y. Cancer Chemother Pharmacol; 2015 Oct; 76(4):793-801. PubMed ID: 26297058 [Abstract] [Full Text] [Related]
22. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy. Zhai XM, Hu QC, Gu K, Wang JP, Zhang JN, Wu YW. Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235 [Abstract] [Full Text] [Related]
23. Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Kiyotani K, Mushiroda T, Kubo M, Zembutsu H, Sugiyama Y, Nakamura Y. Cancer Sci; 2008 May; 99(5):967-72. PubMed ID: 18294295 [Abstract] [Full Text] [Related]
30. The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter. Chen Y, Kissling G, Negishi M, Goldstein JA. J Pharmacol Exp Ther; 2005 Sep 25; 314(3):1125-33. PubMed ID: 15919766 [Abstract] [Full Text] [Related]
31. The influence of granisetron on the pharmacokinetics and pharmacodynamics of docetaxel in Asian lung cancer patients. Miyata M, Yasuda K, Burioka N, Takane H, Suyama H, Shigeoka Y, Endo M, Kurai J, Morita M, Igishi T, Shimizu E. Cancer J; 2006 Sep 25; 12(1):69-72. PubMed ID: 16613665 [Abstract] [Full Text] [Related]
33. Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. Martino A, Sainz J, Manuel Reis R, Moreno V, Buda G, Lesueur F, Marques H, García-Sanz R, Ríos R, Stein A, Dumontet C, Gemignani F, Maria Rossi A, Landi S, Jurado M, Petrini M, Jamroziak K, Campa D, Canzian F. J Hum Genet; 2013 Mar 25; 58(3):155-9. PubMed ID: 23303387 [Abstract] [Full Text] [Related]
34. Effects of intrauterine undernutrition on the expression of CYP3A23/3A1, PXR, CAR and HNF4alpha in neonate rats. Ni S, Wang X, Wang J, Lu S, Zeng S, Zhao Z, Yu L, Chen S. Biopharm Drug Dispos; 2008 Dec 25; 29(9):501-10. PubMed ID: 19058292 [Abstract] [Full Text] [Related]
35. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease. Glas J, Seiderer J, Fischer D, Tengler B, Pfennig S, Wetzke M, Beigel F, Olszak T, Weidinger M, Göke B, Ochsenkühn T, Folwaczny M, Müller-Myhsok B, Diegelmann J, Czamara D, Brand S. Inflamm Bowel Dis; 2011 Sep 25; 17(9):1917-24. PubMed ID: 21830270 [Abstract] [Full Text] [Related]
37. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Sandanaraj E, Lal S, Selvarajan V, Ooi LL, Wong ZW, Wong NS, Ang PC, Lee EJ, Chowbay B. Clin Cancer Res; 2008 Nov 01; 14(21):7116-26. PubMed ID: 18981011 [Abstract] [Full Text] [Related]
38. Transactivation Assays that Identify Indirect and Direct Activators of Human Pregnane X Receptor (PXR, NR1I2) and Constitutive Androstane Receptor (CAR, NR1I3). Pinne M, Ponce E, Raucy JL. Drug Metab Lett; 2017 Nov 01; 11(2):128-137. PubMed ID: 29219065 [Abstract] [Full Text] [Related]
39. Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. Zhou Q, Sparreboom A, Tan EH, Cheung YB, Lee A, Poon D, Lee EJ, Chowbay B. Br J Clin Pharmacol; 2005 Apr 01; 59(4):415-24. PubMed ID: 15801936 [Abstract] [Full Text] [Related]